189 related articles for article (PubMed ID: 9334398)
21. Serotonin transporters upregulate with chronic cocaine use.
Mash DC; Staley JK; Izenwasser S; Basile M; Ruttenber AJ
J Chem Neuroanat; 2000 Dec; 20(3-4):271-80. PubMed ID: 11207425
[TBL] [Abstract][Full Text] [Related]
22. Selective labeling of kappa 2 opioid receptors in rat brain by [125I]IOXY: interaction of opioid peptides and other drugs with multiple kappa 2a binding sites.
Ni Q; Xu H; Partilla JS; de Costa BR; Rice KC; Rothman RB
Peptides; 1993; 14(6):1279-93. PubMed ID: 8134311
[TBL] [Abstract][Full Text] [Related]
23. Induction of Fos-like immunoreactivity by opioids in guinea-pig brain.
Bot G; Chahl LA
Brain Res; 1996 Aug; 731(1-2):45-56. PubMed ID: 8883853
[TBL] [Abstract][Full Text] [Related]
24. Dihydrocodeinone-hydrazone, dihydrocodeinone-oxime, naloxone-3-OMe-oxime, and clocinnamox fail to irreversibly inhibit opioid kappa receptor binding.
Ni Q; Xu H; Partilla JS; de Costa BR; Rice KC; Borsodi A; Hosztafi S; Rothman RB
Neurochem Res; 1994 Sep; 19(9):1159-63. PubMed ID: 7824069
[TBL] [Abstract][Full Text] [Related]
25. Opioid receptor subtypes in the supraoptic nucleus and posterior pituitary gland of morphine-tolerant rats.
Sumner BE; Coombes JE; Pumford KM; Russell JA
Neuroscience; 1990; 37(3):635-45. PubMed ID: 2174133
[TBL] [Abstract][Full Text] [Related]
26. Kappa opioid receptors expressed on three related thymoma cell lines. Differences in receptor-effector coupling.
Lawrence DM; Joseph DB; Bidlack JM
Biochem Pharmacol; 1995 Jan; 49(1):81-9. PubMed ID: 7840787
[TBL] [Abstract][Full Text] [Related]
27. kappa-Opioid receptor agonists prevent sensitization to the conditioned rewarding effects of cocaine.
Shippenberg TS; LeFevour A; Heidbreder C
J Pharmacol Exp Ther; 1996 Feb; 276(2):545-54. PubMed ID: 8632320
[TBL] [Abstract][Full Text] [Related]
28. Age-dependent effects of kappa-opioid receptor stimulation on cocaine-induced stereotyped behaviors and dopamine overflow in the caudate-putamen: an in vivo microdialysis study.
Cortez AM; Charntikov S; Der-Ghazarian T; Horn LR; Crawford CA; McDougall SA
Neuroscience; 2010 Aug; 169(1):203-13. PubMed ID: 20435099
[TBL] [Abstract][Full Text] [Related]
29. The kappa opioid receptor expressed on the mouse R1.1 thymoma cell line down-regulates without desensitizing during chronic opioid exposure.
Joseph DB; Bidlack JM
J Pharmacol Exp Ther; 1995 Mar; 272(3):970-6. PubMed ID: 7891351
[TBL] [Abstract][Full Text] [Related]
30. Molecular mechanisms of agonist-induced desensitization of the cloned mouse kappa opioid receptor.
Raynor K; Kong H; Hines J; Kong G; Benovic J; Yasuda K; Bell GI; Reisine T
J Pharmacol Exp Ther; 1994 Sep; 270(3):1381-6. PubMed ID: 7932192
[TBL] [Abstract][Full Text] [Related]
31. The frequency of cocaine administration impacts cocaine-induced receptor alterations.
Unterwald EM; Kreek MJ; Cuntapay M
Brain Res; 2001 May; 900(1):103-9. PubMed ID: 11325352
[TBL] [Abstract][Full Text] [Related]
32. Effects of kappa-opioid receptor agonists on long-term cocaine use and dopamine neurotransmission.
Collins SL; D'Addario C; Izenwasser S
Eur J Pharmacol; 2001 Aug; 426(1-2):25-34. PubMed ID: 11525767
[TBL] [Abstract][Full Text] [Related]
33. Kappa-opioid receptors are differentially labeled by arylacetamides and benzomorphans.
Rusovici DE; Negus SS; Mello NK; Bidlack JM
Eur J Pharmacol; 2004 Feb; 485(1-3):119-25. PubMed ID: 14757131
[TBL] [Abstract][Full Text] [Related]
34. Assessment of the discriminative stimulus effects of cocaine in the rat: lack of interaction with opioids.
Broadbent J; Gaspard TM; Dworkin SI
Pharmacol Biochem Behav; 1995; 51(2-3):379-85. PubMed ID: 7667357
[TBL] [Abstract][Full Text] [Related]
35. Dopamine transport function is elevated in cocaine users.
Mash DC; Pablo J; Ouyang Q; Hearn WL; Izenwasser S
J Neurochem; 2002 Apr; 81(2):292-300. PubMed ID: 12064476
[TBL] [Abstract][Full Text] [Related]
36. Repeated cocaine administration upregulates kappa and mu, but not delta, opioid receptors.
Unterwald EM; Rubenfeld JM; Kreek MJ
Neuroreport; 1994 Aug; 5(13):1613-6. PubMed ID: 7819531
[TBL] [Abstract][Full Text] [Related]
37. Agonists and antagonists bind to different domains of the cloned kappa opioid receptor.
Kong H; Raynor K; Yano H; Takeda J; Bell GI; Reisine T
Proc Natl Acad Sci U S A; 1994 Aug; 91(17):8042-6. PubMed ID: 8058754
[TBL] [Abstract][Full Text] [Related]
38. Synthesis and structure-opioid activity relationships of trans-(+/-)-3,4-dichloro-N-methyl-N-[4- or 5-hydroxy-2-(1-pyrrolidiny)cyclohexyl]benzeneacetamides.
Cheng CY; Chen CY; Tao PL
J Pharm Pharmacol; 1997 Sep; 49(9):835-42. PubMed ID: 9306249
[TBL] [Abstract][Full Text] [Related]
39. Effect of mu- and kappa-opioid agonists on the electroconvulsive seizure threshold in mice and antagonism by naloxone and MR 2266.
Frey HH
Pharmacol Toxicol; 1988 Mar; 62(3):150-4. PubMed ID: 2836842
[TBL] [Abstract][Full Text] [Related]
40. Kappa opioid antagonist effects of the novel kappa antagonist 5'-guanidinonaltrindole (GNTI) in an assay of schedule-controlled behavior in rhesus monkeys.
Negus SS; Mello NK; Linsenmayer DC; Jones RM; Portoghese PS
Psychopharmacology (Berl); 2002 Oct; 163(3-4):412-9. PubMed ID: 12373442
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
